药品类
Search documents
重药控股跌2.01%,成交额2.08亿元,主力资金净流出181.31万元
Xin Lang Cai Jing· 2025-12-25 02:42
Core Viewpoint - The stock of Chongqing Pharmaceutical Holdings Co., Ltd. has experienced fluctuations, with a recent decline of 2.01% and a year-to-date increase of 18.69% [1] Group 1: Stock Performance - As of December 25, the stock price is reported at 6.35 yuan per share, with a total market capitalization of 10.974 billion yuan [1] - The stock has seen a 7.43% decline over the last five trading days, but a 20.72% increase over the last 20 days and a 24.27% increase over the last 60 days [1] - The company has appeared on the "龙虎榜" (a stock trading leaderboard) twice this year, with the latest instance on December 15, where it recorded a net purchase of 1.58 billion yuan [1] Group 2: Financial Performance - For the period from January to September 2025, the company achieved a revenue of 62.211 billion yuan, reflecting a year-on-year growth of 4.22% [2] - The net profit attributable to shareholders for the same period was 384 million yuan, showing a significant year-on-year increase of 31.41% [2] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders has decreased by 4.05% to 42,000, while the average circulating shares per person increased by 4.22% to 41,112 shares [2] - The company has distributed a total of 864 million yuan in dividends since its A-share listing, with 294 million yuan distributed over the last three years [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 10.091 million shares, an increase of 851,000 shares compared to the previous period [3]
重药控股涨2.17%,成交额5944.35万元,主力资金净流出482.41万元
Xin Lang Cai Jing· 2025-11-11 03:03
Core Viewpoint - The stock of Chongqing Zhongyao Holdings has shown a positive trend with a year-to-date increase of 5.79% and a recent rise of 4.81% over the last five trading days, indicating a strong performance in the pharmaceutical distribution sector [1][2]. Financial Performance - For the period from January to September 2025, Chongqing Zhongyao Holdings reported a revenue of 62.211 billion yuan, reflecting a year-on-year growth of 4.22%. The net profit attributable to shareholders was 384 million yuan, marking a significant increase of 31.41% compared to the previous year [2]. - The company has distributed a total of 864 million yuan in dividends since its A-share listing, with 294 million yuan distributed over the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Chongqing Zhongyao Holdings was 42,000, a decrease of 4.05% from the previous period. The average number of circulating shares per shareholder increased by 4.22% to 41,112 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 10.091 million shares, an increase of 851,000 shares from the previous period, while the Southern CSI 1000 ETF reduced its holdings by 55,600 shares to 7.898 million shares [3]. Stock Market Activity - On November 11, the stock price of Chongqing Zhongyao Holdings rose by 2.17% to 5.66 yuan per share, with a trading volume of 59.4435 million yuan and a turnover rate of 0.62%. The total market capitalization reached 9.782 billion yuan [1]. - The net outflow of main funds was 4.8241 million yuan, with large orders showing a buy of 7.9016 million yuan and a sell of 12.8199 million yuan, indicating mixed investor sentiment [1].